Navigation Links
Laureate Pharma to Add More Manufacturing Capacity
Date:9/18/2008

- Laureate To Add Single-Use Bioreactor (S.U.B.) To Its Portfolio Of Assets

-

PRINCETON, N.J., Sept. 18 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that it is increasing its existing manufacturing capacity by adding two Single-Use Bioreactors (S.U.B.). Acquisition of a 250L and a 1000L S.U.B. will give Laureate greater flexibility in meeting the varying needs of its clients.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080131/NETH020LOGO )

The S.U.B. is a single-use alternative to conventional stirred tank bioreactors. The S.U.B. consists of a permanent stainless steel outer support container and a S.U.B. Bioprocess Container (BPC(R)), integrated with an existing bioreactor control system. This makes the S.U.B. a flexible, rapid and economic option to update or increase the bioreactor capacity. The S.U.B. will supplement Laureate's current single-use bioreactors -- Wave Bioreactors(R) and hollow-fiber systems -- as well as the conventional stainless steel stirred-tank bioreactors.

"We are excited about adding the S.U.B. to increase our bioreactor capacity. It is a scalable technology that will support the demand from our growing client base and meet their needs and manufacturing objectives," said Robert J. Broeze, Ph. D., President & Chief Executive Officer of Laureate. "The HyClone S.U.B. provides us with all the advantages of single-use bioprocessing, while maintaining aspect ratios and agitation mechanisms comparable to traditional stainless steel stirred-tank bioreactors."

About Laureate Pharma, Inc.

Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, New Jersey. Laureate Pharma offers superior bioprocessing services that accelerate new products from development through production. Laureate provides a wide range of specialized services from process design and development to full-scale cGMP production, purification, aseptic filling, testing, validation, analytical services, and regulatory support. Laureate is focused on two active segments of the biopharmaceutical industry: monoclonal antibodies and recombinant protein products. For more information, contact Michael Cavanaugh, Vice President Sales, Marketing, and Business Development at (609) 919-3400, or info@laureatepharma.com or visit http://www.laureatepharma.com.


'/>"/>
SOURCE Laureate Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ARUP Laboratories ARUP Consult(R) Recognized as a Computerworld Honors Program Laureate
2. Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC
3. Laureate Pharma Reports Record Growth for 2007
4. Laureate Pharma Appoints Gary Swan as Vice President of Operations
5. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
6. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
7. American Scientists Named as Laureates of the 2008 (24th) Japan Prize
8. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
9. DFB Sells Coria Labs to Valeant Pharmaceuticals
10. Quark Pharmaceuticals Announces Poster Presentations at RNAi Europe 2008
11. Pharmatek Announces Official Opening of New Highly-Potent & Cytotoxic Development and Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... San Francisco, CA (PRWEB) , ... February 21, ... ... is pleased to announce that Dr. Trevor Heritage has joined its executive team ... a revolutionary system designed to provide insights to help improve the diagnosis and ...
(Date:2/21/2017)... (PRWEB) , ... February 21, 2017 , ... ... GMP cell therapy manufacturing facility at its headquarters laboratory in Poway, California. ... utilizing the experience of both in-house personnel and consultants, VetStem constructed and validated ...
(Date:2/21/2017)... a returning partner of the Amgen Tour of California , ... of the men,s and women,s events for the next five editions ... of California will mark the start of ... cycling teams in the world racing from Northern to ... from Heart Disease TM Women,s Race empowered with SRAM ...
(Date:2/21/2017)... 2017   Invitae Corporation (NYSE: NVTA), one ... that members of the company,s management team will present ... Conference on Monday, March 6, 2017 at approximately 4:00 ... Boston, Massachusetts . The live, ... visiting the investors section of the company,s website at ...
Breaking Biology Technology:
(Date:1/30/2017)... 30, 2017   Invitae Corporation (NYSE: ... information companies, today announced that it will report its ... 2017 guidance on Monday, February 13, 2017, and Invitae,s ... at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... briefly review financial results, guidance, and recent developments and ...
(Date:1/24/2017)... PHILADELPHIA , Jan. 24, 2017  It ... a baby,s sock that monitors vital signs and ... instance, an infant,s oxygen saturation level drops. But ... undue alarm to parents, with no evidence of ... "These devices are marketed aggressively to parents of ...
(Date:1/18/2017)... 18, 2017  In vitro diagnostic (IVD) companies were ... acquisitions (M&A), and Kalorama Information expects that trend to ... been shifting. Generally, uncertainty in reimbursement and healthcare reform ... has changed the acquisitions landscape. Instead of looking to ... buying partners outside of their home country and also ...
Breaking Biology News(10 mins):